CERS

#3124
Cerus Corp
2.01 USD
+4.69%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
2.01
2.01
Year Range
1.15
2.96
Daily Change
+4.69%
Monthly Change
+18.93%
6 month change
+25.62%
Year Change
+50.00%
Previous Close
1.92
Open
2.01
Bid
Ask
Low
2.01
High
2.01
Volume
36
Open full chart

Financials

Overview Statement Statistics
Quarterly Annual
Income statement Balance sheet Cash flow
Value 202020212022202320242025

Cerus Corporation

Cerus Corporation is an American multinational biotechnology company headquartered in Concord, California that develops and provides a treatment system to pathogen-reduce human blood products for the healthcare industry.

News